Where Hexarelin Fits in the GH Ecosystem Hexarelin occupies a specific niche in the growth hormone research landscape: Strongest acute GH secretagogue in the GHRP class Only GHRP with robust cardiac research (CD36-mediated, GH-independent) Highest side-effect burden among GHRPs (prolactin, cortisol, desensitization) Best suited for combination protocols where its dose can be lowered via GHRH synergy Poor choice for long-term continuous use due to receptor downregulation For most GH research, Ipamorelin paired with CJC-1295 is the more practical combination cleaner side-effect profile, less desensitization, and still meaningful GH elevation
Those with Certain Chronic Illnesses: If you have a chronic illness like severe diabetes, liver failure, or others, whether to get an IV should be discussed with your doctor
Faisal Qureshi, M.D., M.B.A., Professor of Surgery in the Division of Pediatric Surgery
So there's two, two points I would make there, right
Due to the nature of our products, all sales are final